DOI QR코드

DOI QR Code

Antibiotic Resistance and Virulence Potentials of Shiga Toxin-Producing Escherichia coli Isolates from Raw Meats of Slaughterhouses and Retail Markets in Korea

  • Received : 2015.02.13
  • Accepted : 2015.06.18
  • Published : 2015.09.28

Abstract

In this study, the prevalence of Shiga toxin-producing Escherichia coli (STEC) was investigated among raw meat or meat products from slaughterhouses and retail markets in South Korea, and their potential for antibiotic resistance and virulence was further analyzed. A total of 912 raw meats, including beef, pork, and chicken, were collected from 2008 to 2009. E. coli strains were frequently isolated in chicken meats (176/233, 75.9%), beef (102/217, 42.3%), and pork (109/235, 39.2%). Putative STEC isolates were further categorized, based on the presence or absence of the Shiga toxin (stx) genes, followed by standard O-serotyping. Polymerase chain reaction assays were used to detect the previously defined virulence genes in STEC, including Shiga toxins 1 and Shiga toxin 2 (stx1 and 2), enterohemolysin (ehxA), intimin (eaeA), STEC autoagglutination adhesion (saa), and subtilase cytotoxin (subAB). All carried both stx1 and eae genes, but none of them had the stx2, saa, or subAB genes. Six (50.0%) STEC isolates possessed the ehxA gene, which is known to be encoded by the 60-megadalton virulence plasmid. Our antibiogram profiling demonstrated that some STEC strains, particularly pork and chicken isolates, displayed a multiple drug-resistance phenotype. RPLA analysis revealed that all the stx1-positive STEC isolates produced Stx1 only at the undetectable level. Altogether, these results imply that the locus of enterocyte and effacement (LEE)-positive strains STEC are predominant among raw meats or meat products from slaughterhouses or retail markets in Korea.

Keywords

Introduction

Shiga toxin-producing Escherichia coli (STEC; also known as verotoxin-producing E. coli, VTEC) has emerged and is recognized as an important zoonotic food-borne pathogen and risk to public health [11, 29]. The microorganism produces Shiga toxins (Stxs), which belong to the AB5-type bacterial toxin family with a potent cytopathic effect on mammalian cells [10]. In addition to toxin production, another virulence-associated factor expressed by STEC is an adhesin called intimin (the chromosomally encoded eae gene product), which is responsible for the intimate attachment of STEC to intestinal epithelial cells, causing attaching and effacing lesions in the intestinal mucosa [17, 47]. The microorganism also carries another virulence factor, EhxA (the enterohemorrhagic E. coli hemolysin), which acts as a pore-forming cytolysin on eukaryotic cells [40]. Recently, the STEC autoagglutinating adhesin (Saa) has been characterized to be required for full virulence of STEC [16].

Although the most common STEC serotype associated with human outbreaks is known to be the serotype O157:H7, there is a growing recognition that non-O157 STEC serotypes have also been responsible for several human illnesses. Supporting this notion, recent studies have reported that not only STEC O157:H7 but also 100 additional non-O157 STEC serotypes were isolated from beef-related foods or food products. Thus, non-O157 STEC is now recognized as a potential zoonotic pathogen worldwide [5, 9, 14, 44]. Moreover, USDA-FSIS announced that ground beef and its precursor products would be routinely analyzed for the non-O157 STEC serogroups O26, O45, O103, O111, O121, and O145 [44, 45] because these serogroups have been found responsible for 70% of the reported STEC-related illnesses in the US [4]. In Korea, pathogenic E. coli-related food-poisoning cases are more common than other pathogenic bacteria [21].

In general, most outbreaks of human infection by STEC occur through the ingestion of contaminated foods or drinking water, including undercooked meats, unpasteurized milk and dairy products, vegetables, or fruit juice. Direct contact with animal carriers or the environment can also cause the infection [27, 37]. Therefore, the identification of the sources of infection is an important step towards decreasing the prevalence of this pathogen as well as reducing the risk of infection of humans [1, 31].

Cattle are regarded as the main reservoir in many countries [28, 32, 33]. However, previous studies have reported that a variety of livestock, such as sheep, goats, pigs, and chickens, can also carry STEC in their gastrointestinal tracts [13, 26, 32, 34]. Therefore, STEC contamination among retail meat products is an important threat to public health and food safety. To date, little information is available on the prevalence of STEC from raw meat in South Korea, because STEC O157:H7 has only been legally prohibited in the standards for the processing and ingredients specifications of livestock products in Korea. Thus, the prevalence and virulence potentials of STEC isolates from raw beef, pork, and chicken meats from slaughterhouses and retail markets in Korea were evaluated in this study [35, 38].

 

Materials and Methods

Sample Collection and Preparation

A total of 912 meat products were collected in South Korea; 473 samples in 2008 and 439 samples in 2009 (Table 2). Samples were taken either from the meat surfaces from cattle, pigs, and chickens in slaughterhouses or from raw beef, pork, and chicken meats packaged in retail markets. Samples were handled according to the guideline in the Standards for Processing and Ingredients of Specifications Livestock Products in Korea [24]. Sponges moistened with buffered peptone water (BPW; Oxoid, Hampshire, UK) were wiped in the flank, brisket, and rump of bovine and swine carcasses. BPW was added into the sponge and stomached; the solution was analyzed for detection of E. coli. For poultry, whole bird carcasses were placed into sterile bags and 400 ml of sterile BPW was added. The bag was thoroughly shaken. Both wipedsponge and carcass-rinsing solutions were used as sample solutions for further analyses. In the case of packaged meat samples from retail markets, 25 g was taken and 9-fold of diluents (BPW) was added and stomached. All samples were analyzed within 36 h after collection.

Isolation of E. coli

Twenty-five milliliters of the sample solutions was blended in 225 ml of Brilliant Green Bile Broth and incubated for 24-48 h at approximately 35–37℃. One loop of the enrichment culture was streaked onto Eosin Methylene Blue agar (Oxoid, UK). Plates were examined for typical E. coli colonies after an approximately 18 to 24 h incubation at 35–37℃. From each positive sample, typical colonies were transferred onto Tryptone Soy Agar (BD, US, USA) and incubated at 35–37℃ for approximately 18–24 h. Each isolate was finally identified using the Vitek II Compact system (bioMerieux, France).

Detection of the Major Virulence Genes in STEC Isolates by Polymerase Chain Reaction (PCR)

To detect the previously defined virulence genes in the STEC isolates, PCR analyses were performed using the primers specific to the major STEC virulence genes that encode Shiga toxin (stx1 and 2), enterohemolysin (ehxA), intimin (eaeA), STEC autoagglutination adhesin (saa), and subtilase cytotoxin (subAB), as shown in Table 1 [18, 30, 33, 43]. Production of Stxs was quantified by a commercially available reverse phase latex agglutination (RPLA) kit (VTECRPLA, SEIKEN; Denka Seiken Co., Japan), and tested in accordance with the manufacturer's instructions.

Table 1.Primers used in this study.

O-Serotyping and Antibiogram Profiling of the STEC Isolates

The O-serotypes of STEC isolates were determined by using E. coli antisera “SEIKEN” set 1 (Denka Seiken Co.). An antibiogram of individual STEC isolates was examined by the determination of the minimal inhibitory concentrations (MIC) according to the guideline of the Clinical and Laboratory Standard Institute [7]. Using Sensititre plates (Trek Diagnostic System, UK), we diluted samples serially in broth and then incubated at 35℃ to 37℃ for 18 h. The MICs were read in an Auto Reader (Trek).

Detection of the Expanded Spectrum Beta-Lactamase (ESBL)

After incubation of peptone water with the sample solution, the enrichment broth was streaked on ESBL-bx agar plates (bioMerieux) at 37℃ for approximately 18–24 h. Colonies on the ESBL-bx agar plates were subcultured onto blood agar (Asan Pharmaceutical, Seoul, Korea ) plates and further identified using the Vitek II Compact system. To confirm the ESBL phenotype, a standard double-disk method was applied using cefotaxime/cefotaxime + clavulanic acid and ceftazidime/ceftazidime + clavulanic acid by E-test (AB Biodisk). The E-test with direct reading of the MIC was performed according to the manufacturer guidelines. The MICs of cefotaxime and ceftazidime, alone and in combination with clavulanic acid, were determined by broth microdilution according to CLSI guidelines using Trek microbroth dilution panels (Thermo Scientific). E. coli ATCC 25922 was used as a quality control. [7].

 

Results

Prevalence of STEC in Meat Products

In this study, a total of 387 (56.5%) and 82 (36.1%) E. coli strains were isolated from the 685 raw meat samples in slaughterhouses and 227 meat samples in retail markets, respectively, during the experimental period (Table 2). E. coli strains were frequently isolated in chicken meats (176/233, 75.9%), beef (102/217, 42.3%), and pork (109/235, 39.2%).

Table 2.Prevalence of STEC in meat products in Korea, 2008–2009.

Serotype of E. coli and Virulence Gene of STEC Isolates

Twelve (2.6%) of the 469 E. coli isolates contained the stx genes, of which 11 isolates originated from the slaughterhouse samples (Table 2). The stx genes were found in the six pork samples, but in only two of the beef samples (Table 2). As shown in Table 3, 12 STEC isolates belonged to the 11 different O-serogroups, which were all non-O157 serotypes. All the isolates carried both stx1 and eae genes, but none of them had the stx2, saa, or subAB genes. Six (50.0%) STEC isolates possessed the ehxA gene, which are known to be plasmid-encoded. However, RPLA analysis could not detect Stx1 production from all the STEC isolates although they were all positive for the PCR with the stx1-specific primers, which implies that all the STEC isolates might produce Stx1 only at the basal level.

Table 3.Serotype of E. coli and the presence of the major virulence genes in STEC isolates.

Antibiotic Resistance Profiles of STEC Isolates

Through the 15 antibiogram profiles, the MIC level of most STEC strains was more than 4 μg/ml. Interestingly, chicken isolates of STEC showed higher resistance to the antibiotics evaluated in this study than did beef isolates (data not shown). Most of the E. coli strains had antibiotic resistance to ampicillin (10/12; 83.3%), tetracycline (8/12; 83.3%), and streptomycin (11/12; 91.7%) (Table 4). Some STEC strains, especially pork and chicken isolates, displayed a multiple drug-resistance phenotype. Among them, the three strains of E. coli from pork meats showed resistance (64 μg/ml) to florfenicol (Table 4). However, there were no ESBL producers among all the STEC isolates (Table 4).

Table 4.aCLSI breakpoints for Escherichia coli. bCIPARS breakpoints for Escherichia coli. cNot applicable. dNo breakpoints in CLSI table and CIPARS table.

 

Discussion

The ability of STEC to cause disease is related to the production of one or more Stxs and other virulence factors such as such as intimin (eae), Saa (saa), and EhxA (ehxA). By detection of these virulence genes, STEC can be further characterized [15-17, 40]. Twelve (2.6%) STEC isolates in the present study all carried the stx1 gene and eae gene, but none of them had the stx2, saa, and subAB genes. Six (50.0%) STEC isolates also possessed the ehxA gene. It was contrary to other previous results reported. Lee et al. [20] reported that 39 pathogenic E. coli were isolated between 2004 and 2006, of which 14 isolates were categorized into enterohemorrhagic E. coli (EHEC) in Korea.

The prevalence of STEC isolates in the previous study was 4.1%, 14.9%, and 4.6% in retail beef, pork, and poultry meats, respectively [20]. However, the prevalence of STEC isolates in this study was 28.0%, 26.0%, and 45.0% in beef, pork, and poultry meats, respectively, which turned out to be higher than that observed in the previous study [20]. In contrast, Choi et al. [6] reported that there were no E. coli isolates with the stx genes, although the prevalence of E. coli isolates from retail pork and poultry meats was similar to our results. Meanwhile, it was reported in the US that STEC isolates collected from 1983 to 2002 possessed stx1 (61%), stx2 (22%), eae (84%), and ehxA (86%) genes [4]. They also reported that 61% of human non-O157 STEC isolates contained stx1 alone, 21% had stx2 alone, 18% carried both stx1 and stx2, and 84% of those human isolates harbored eae [4]. The difference in the prevalence of virulence genes from STEC between the US and Korea may reflect the nature of STEC isolates, the conditions of the raising and husbandry practices for animal, climates, and/or variations in STEC isolates from one geographical region to another [8, 12, 34].

Several studies have examined the prevalence of STEC in swine, which seems to be a major source of STEC isolates from raw meats and meat products from our study. STEC was detected in 22% of pigs from Switzerland [19], 30.2% of pigs from Germany [46], 4.5% of pigs from Argentina [23], and 0.4% of pigs from South Africa [22]. Epidemiological studies suggest that non-O157 strains cause 20% to 50% of STEC infections, which cause approximately 169,000 illnesses annually in the US [39]. More than 70% of non-O157 STEC infections are caused by serogroups O26, O103, O111, O145, O91, O113, O128, O45, and O121 [2, 13]. Recently, it has been suggested that non-O157 STEC strains are a major problem in many European countries [7]. The difference in the prevalence of STEC in terms of reported cases, major serotypes, carriage of major virulence genes, and antibiogram profiles might be due to samples of animal species, husbandry practices (such as stocking densities, types of feed offered), and prevailing climatic conditions, which likely account for the variations in STEC isolates from one geographical region to another [8, 12, 34].

As antibiotics are used against pathogenic infection, the emergency and spread of antibiotic resistance become an important problem in the clinical practice. According to a previous report, sulfisoxazole has the most common antimicrobial resistance, followed by tetracycline, streptomycin, ampicillin, trimethoprim, chloramphenicol, and neomycin [25]. Moreover, it has been reported that over 50% of their isolates displayed antimicrobial resistance against sulfamethoxazole, cephalothin, and tetracycline, and 20% of them against ampicillin and gentamicin [41]. The acquisition of antibiotic resistance in both commensal and pathogenic strains has become an important public health issue [36]. The development and persistence of antibiotic resistance in commensal and non-pathogenic bacteria are worldwide concerns, because they are thought to act as a reservoir of resistance genes capable of transferring those genes to other food-borne and zoonotic pathogens [10, 23]. In particular, retail foods, especially meat and meat products, may be an important vehicle for community-wide dissemination of antimicrobial-resistant E. coli and extra-intestinal pathogenic E. coli [42]. In this study, 50% of E. coli isolates showed the highest MICs against streptomycin and tetracycline. According to this result, most of the STEC isolates are considered to have high resistance to streptomycin and tetracycline in Korea.

In conclusion, our finding suggested a low level of STEC found from raw meats or meat products from slaughterhouses or retail markets in Korea, and that the locus of enterocyte and effacement (LEE)-positive STEC is predominant. Further studies are needed to determine their biological significance during host infection and the capabilities for propagation of their antibiotic resistance.

References

  1. Ayala CO, Moreno RAC, Martinez MB, Castro PAF, Bando SY. 2012. Determination of flagellar types by PCR-RFLP analysis of enteropathogenic Escherichia coli (EPEC) and Shiga toxin-producing E. coli (STEC) strains isolated from animals in São Paulo, Brazil. Res. Vet. Sci. 92: 18-23. https://doi.org/10.1016/j.rvsc.2010.10.025
  2. Bettelheim KA. 2007. The non-O157 Shiga-toxigenic (verocytotoxigenic) Escherichia coli; under-rated pathogens. Crit. Rev. Microbiol. 33: 67-87. https://doi.org/10.1080/10408410601172172
  3. Beutin L, Miko A, Krause G, Pries K, Haby S, Steege K, Albrecht N. 2007. Identification of human-pathogenic strains of Shiga toxin-producing Escherichia coli from food by a combination of serotyping and molecular typing of Shiga toxin genes. Appl. Environ. Microbiol. 73: 4769-4775. https://doi.org/10.1128/AEM.00873-07
  4. Brooks TJ, Sowers EG, Wells JG, Greene KD, Griffin PM, Hoekstra RM, Strockbine NA. 2005. Non-O157 Shiga toxin–producing Escherichia coli infections in the United States, 1983–2002. J. Infect. Dis. 192: 1422-1449. https://doi.org/10.1086/466536
  5. Coombes BK, Gilmour MW, Goodman CD. 2011. The evolution of virulence in non-O157 Shiga toxin-producing Escherichia coli. Frontiers Microbiol. 2: 1-3. https://doi.org/10.3389/fmicb.2011.00090
  6. Choi SK, Lee MH, Lee BH, Jung JY, Choi C. 2010. Virulence factor profiles of Escherichia coli isolated from pork and chicken meats obtained from retail markets. Kor. J. Food Sci. Anim. Resour. 30: 148-153. https://doi.org/10.5851/kosfa.2010.30.1.148
  7. CLSI. 2008. Performance standards for antimicrobial disk and dilution susceptibility tests or bacteria isolated from animals; Approved Standard, 3rd Ed. Vol. 28. Clinical and Laboratory Standards Institute, Wayne, PA, USA.
  8. Díaz-Sánchez S, Sánchez S, Herrera-León S, Porrero C, Blanco J, Dahbi, Blanco JE, et al. 2013. Prevalence of Shiga toxinproducing Escherichia coli, Salmonella spp. and Campylobacter spp. in large game animals intended for consumption: relationship with management practices and livestock influence. Vet. Microbiol. 163: 274-281. https://doi.org/10.1016/j.vetmic.2012.12.026
  9. EFSA. 2007. European Food Safety Authority. Scientific opinion of the panel on biological hazards on a request from EFSA on monitoring of verotoxigenic Escherichia coli. EFSA J. 579: 1-61.
  10. Evans J, Wilson A, Willshaw GA, Cheasty T, Tompkins DS, Wheeler JG, Smith HR. 2002. Vero cytotoxin-producing Escherichia coli in a study of infectious intestinal disease in England. Clin. Microbiol. Infect. 8: 183-186. https://doi.org/10.1046/j.1469-0691.2002.00364.x
  11. Fernández D, Sanz ME, Parma AE, Padola NL. 2012. Characterization of Shiga toxin producing Escherichia coli isolated from newborn, milk-fed, and growing calves in Argentina. J. Dairy Sci. 95: 5340-5343. https://doi.org/10.3168/jds.2011-5140
  12. Gautam R, Bani-Yaghoub M, Neill WH, Döpfer D, Kaspar C, Ivanek R. 2011. Modeling the effect of seasonal variation in ambient temperature on the transmission dynamics of a pathogen with a free-living stage: example of Escherichia coli O157:H7 in a dairy herd. Prev. Vet. Med. 102: 10-21. https://doi.org/10.1016/j.prevetmed.2011.06.008
  13. Ghanbarpour R, Kiani M. 2013. Characterization of non-O157 Shiga toxin-producing Escherichia coli isolates from healthy fat-tailed sheep in southeastern of Iran. Trop. Anim. Health Prod. 45: 641-648. https://doi.org/10.1007/s11250-012-0271-5
  14. Grant MA, Hedberg C, Johnson R, Harris J, Logue CM, Meng J, Sofos N, Dickson JS. 2011. The significance of non-O157 Shiga toxin-producing Escherichia coli in food. Food Protect. Trends 31: 33-56.
  15. Growther L, Lullu PK, Sukirtha K, Niren Andrew S. 2013. Biotyping, molecular characterization and screening for antibacterial phytochemicals against Shiga toxin producing E. coli from cattle. Arch. Appl. Sci. Res. 5: 178-182.
  16. Gyles CL. 2007. Shiga toxin-producing Escherichia coli: an overview. J. Anim. Sci. 5: E45-E62. https://doi.org/10.2527/jas.2006-508
  17. Helmy OM, Ragab YM, Hussein M. 2013. Multiplex polymerase chain reaction (PCR) for the detection of diarrheagenic Escherichia coli and Shigella directly from stool. Afr. J. Microbiol. Res. 7: 4368-4372.
  18. Jenkins C, Perry NT, Cheasty T, Shaw DJ, Frankel G, Dougan G, et al. 2003. Distribution of the saa gene in strains of Shiga toxin-producing Escherichia coli of human and bovine origins. J. Clin. Microbiol. 41: 1775-1778. https://doi.org/10.1128/JCM.41.4.1775-1778.2003
  19. Kaufmann M, Zweifel C, Blanco M, Blanco JE, Blanco J, Beutin L, Stephan R. 2006. Escherichia coli O157 and non-O157 Shiga toxin-producing Escherichia coli in fecal samples of finished pigs at slaughter in Switzerland. J. Food. Prot. 9: 260-266.
  20. Lee YG, Jang IH, Hwang GI, Rhee SM. 2009. Prevalence and classification of pathogenic Escherichia coli isolated from fresh beef, poultry, and pork in Korea. Int. Food Microbiol. 134: 196-200. https://doi.org/10.1016/j.ijfoodmicro.2009.06.013
  21. MFDS (Ministry of Food and Drug Safety). Outbreak Food Poisoning Statistic System. Available at http://www.kfda.go.kr/e-stat (accessed 3 August 2012).
  22. Mohlatlole RP, Madoroba E, Muchadeyi FC, Chimonyo M, Kanengoni T, Dzomba EF. 2013. Virulence profiles of enterotoxigenic, shiga toxin and enteroaggregative Escherichia coli in South African pigs. Trop. Anim. Health Prod. 45: 1399-1405. https://doi.org/10.1007/s11250-013-0377-4
  23. Moredo FA, Cappuccio JA, Insarralde L, Perfumo CJ, Quiroga MA, Leotta GA. 2012. Genotypic characterization of toxigenic Escherichia coli isolated from pigs with postweaning diarrhea (PWD) and edema disease (ED). Rev. Argent. Microbiol. 44: 85-88.
  24. MFDS (Ministry of Food and Drug Safety). Standards for processing and ingredients specifications of livestock products (MFDS notice 2013-244).
  25. Mora A, Blanco EJ, Blanco M, Pilar Alonso M, Dhabi G, Echeita A, et al. 2005. Antimicrobial resistance of Shiga toxin (verotoxin)-producing Escherichia coli O157:H7 and non-O157 strains isolated from humans, cattle, sheep and food in Spain. Res. Microbiol. 156: 793-806. https://doi.org/10.1016/j.resmic.2005.03.006
  26. Nataro JP, Kaper JB. 1998. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11: 142-201.
  27. Pacheco AR, Sperandio V. 2012. Shiga toxin in enterohemorrhagic E. coli: regulation and novel anti-virulence strategies. Front. Cell Infect. Microbiol. 2: 81. https://doi.org/10.3389/fcimb.2012.00081
  28. Park SH, Kim SH, Seo JJ, Kee HY, Kim MJ, Seo KW, et al. 2006. An outbreak of inapparent non-O157 enterohemorrhagic Escherihia coli infection. Kor. J. Med. 70: 495-504.
  29. Paris A, Bonardi S, Bacci C, Boni E, Salmi F, Bassi L, Brindani F. 2010. Improvement of biomolecular methods for the identification and typing of Escherichia coli O157:H7 isolated from raw meat. Vet. Res. Commun. 34: S145-S148. https://doi.org/10.1007/s11259-010-9398-x
  30. Paton AW, Srimanote P, Woodrow MC, Paton JC. 2001. Characterization of Saa, novel autoagglutinating adhesin produced by locus of enterocyte effacement-negative Shigatoxigenic Escherichia coli strains that are virulent for humans. Infect. Immun. 69: 6999-7009. https://doi.org/10.1128/IAI.69.11.6999-7009.2001
  31. Pedersen K, Clark L, Andelt WF, Salman MD. 2006. Prevalence of Shiga toxin-producing Escherichia coli and Salmonella enterica in rock pigeons captured in Fort Collins, Colorado. J. Wildl. Dis. 42: 46-55. https://doi.org/10.7589/0090-3558-42.1.46
  32. Pinaka O, Pournaras S, Mouchtouri V, Plakokefalos E, Katsiaflaka A, Kolokythopoulou F, et al. 2013. Shiga toxinproducing Escherichia coli in Central Greece: prevalence and virulence genes of O157:H7 and non-O157 in animal feces, vegetables, and humans. Eur. J. Clin. Microbiol. Infect. Dis. 32: 1401-1408. https://doi.org/10.1007/s10096-013-1889-6
  33. Pradel N, Livrelli V, Champs C, Palcoux JB, Reynaud A, Scheutz F, et al. 2000. Prevalence and characterization of Shiga toxin-producing Escherichia coli isolated from cattle, food, and children during a one-year prospective study in France. J. Clin. Microbiol. 38: 1023-1031.
  34. Rajkhowa S, Sarma DK. 2014. Prevalence and antimicrobial resistance of porcine O157 and non-O157 Shiga toxinproducing Escherichia coli from India. Trop. Anim. Health Prod. 46: 931-937. https://doi.org/10.1007/s11250-014-0587-4
  35. Read SC, Gyles CL, Clarke RC, Lior H, McEwen S. 1990. Prevalence of verocytotoxigenic Escherichia coli in ground beef, pork and chicken in Ontario. Epidemiol. Infect. 105: 11-20. https://doi.org/10.1017/S0950268800047592
  36. Saei DH, Ahmadi E, Kazemnia A, Ahmadinia M. 2010. Molecular identification and antibiotic susceptibility patterns of Escherichia coli isolates from sheep faeces samples. Comp. Clin. Pathol. 21: 467-473. https://doi.org/10.1007/s00580-010-1134-y
  37. Sanchez S, Martnez R, Rey J, Garca A, Blanco J, Blanco M, et al. 2010. Pheno-genotypic characterisation of Escherichia coli O157:H7 isolates from domestic and wild ruminants. Vet. Microbiol. 142: 445-449. https://doi.org/10.1016/j.vetmic.2009.10.009
  38. Sasaki Y, Tsujiyama Y, Kusukawa M, Murakaki M, Katayama S, Yamada Y. 2011. Prevalence and characterization of Shiga toxin-producing Escherichia coli 157 and O26 in beef farms. Vet. Microbiol. 150: 140-145. https://doi.org/10.1016/j.vetmic.2010.12.024
  39. Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson M, Roy L, et al. 2011. Foodborne illness acquired in the United States major pathogens. Emerg. Infect. Dis. 17: 7-15. https://doi.org/10.3201/eid1701.P11101
  40. Schmidt H, Beutin L, Karch H. 1995. Molecular analysis of the plasmid-encoded hemolysin of Escherichia coli O157:H7 strain EDL 933. Infect. Immun. 63: 1055-1061.
  41. Schroeder CM, Zhao C, DebRoy C, Torcolini J, Zhao S, White DG, et al. 2002. Antimicrobial resistance Escherichia coli O157 isolated from humans, cattle, swine, and food. Appl. Eenviron. Microbiol. 68: 576-581. https://doi.org/10.1128/AEM.68.2.576-581.2002
  42. Sunde M, Norstrom M. 2006. The prevalence of associations between and conjugal transfer of antibiotic resistance genes in Escherichia coli isolated from Norwegian meat and meat products. J. Antimicrob. Chemother. 58: 741-747. https://doi.org/10.1093/jac/dkl294
  43. Tozzoli R, Caprioli A, Cappannella S, Michelacci V, Marziano ML, Morabito S. 2010. Production of the subtilase AB5 cytotoxin by Shiga toxin-negative Escherichia coli. J. Clin. Microbiol. 48: 178-183. https://doi.org/10.1128/JCM.01648-09
  44. USDA. 2011. United States Department of Agriculture. Draft risk profile for pathogenicon-O157 Shiga toxin-producing Escherichia coli (non-O157 STEC). Available at http://www.fsis.usda.gov/PDF/Non_O157_STEC_Risk_Profile.pdf (Accessed 13-April-2012).
  45. USDA. 2012. United States Department of Agriculture. Shiga toxin-producing Escherichia coli in certain raw beef products. Docket No. FSIS-2010-0023. Federal Register 77: 9888-9889.
  46. Von Muffling T, Smaijlovic M, Nowak B, Sammet K, Bulte M, Klein G. 2007. Preliminary study of certain serotypes, genetic and antimicrobial resistance profiles of verotoxigenic Escherichia coli (VTEC) isolated in Bosnia and Germany from cattle or pigs and their products. Int. J. Food Microbiol. 117: 185-191. https://doi.org/10.1016/j.ijfoodmicro.2006.08.003
  47. Wang H, Paton JC, Paton AW. 2007. Pathologic changes in mice induced by subtilase cytotoxin, a potent new Escherichia coli AB5 toxin that targets the endoplasmic reticulum. J. Infect. Dis. 196: 1093-1101. https://doi.org/10.1086/521364

Cited by

  1. Prevalence, virulence potential, and pulsed-field gel electrophoresis profiling of Shiga toxin-producing Escherichia coli strains from cattle vol.9, pp.None, 2015, https://doi.org/10.1186/s13099-017-0169-x
  2. Escherichia coli O26 and O113:H21 on Carcasses and Beef from a Slaughterhouse Located in Mato Grosso, Brazil vol.15, pp.10, 2018, https://doi.org/10.1089/fpd.2018.2431
  3. Pathogenic and phylogenetic characteristics of non-O157 Shiga toxin-producing Escherichia coli isolates from retail meats in South Korea vol.19, pp.2, 2015, https://doi.org/10.4142/jvs.2018.19.2.251
  4. Antibiotic‐resistant Shiga toxin‐producing Escherichia coli: An overview of prevalence and intervention strategies vol.66, pp.1, 2015, https://doi.org/10.1111/zph.12533
  5. Isolation and Characterization of Non-O157 Shiga Toxin-Producing Escherichia coli in Foods Sold at Retail Markets in China vol.83, pp.3, 2015, https://doi.org/10.4315/0362-028x.jfp-19-025
  6. Isolation and molecular characterization of multidrug-resistant Escherichia coli from chicken meat vol.10, pp.1, 2015, https://doi.org/10.1038/s41598-020-78367-2
  7. Genomic features and antimicrobial resistance patterns of Shiga toxin‐producing Escherichia coli strains isolated from food in Chile vol.68, pp.3, 2015, https://doi.org/10.1111/zph.12818
  8. Genomic Epidemiology of Shiga Toxin-Producing Escherichia coli Isolated from the Livestock-Food-Human Interface in South America vol.11, pp.7, 2015, https://doi.org/10.3390/ani11071845